Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

1.930 -0.020 (-1.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,113
Open 1.920
Bid (Size) 1.680 (1)
Ask (Size) 1.910 (20)
Prev. Close 1.950
Today's Range 1.920 - 1.930
52wk Range 1.390 - 3.390
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immuron hails record monthly sales of Travelan
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan®.... 
Via TheNewswire.com
Immuron hails record monthly sales of Travelan
--News Direct-- 
Via News Direct

Performance

YTD
-11.87%
-11.87%
1 Month
+1.58%
+1.58%
3 Month
-3.02%
-3.02%
6 Month
+6.32%
+6.32%
1 Year
-13.06%
-13.06%

More News

Read More
Immuron achieves record monthly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
Via News Direct
FDA Lifts Clinical Hold From Immuron's New Campylobacter ETEC Therapeutic Study
Via Benzinga
Why Immuron Stock Is Soaring Today
Via Benzinga
Immuron to present at the Military Health System Research Symposium
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
Via TheNewswire.com
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Bioshares
From Immuron Limited
Via GlobeNewswire
Immuron Business Update - Ateria Health launches Juvia™ in Australia
From Immuron Limited
Via GlobeNewswire
Immuron FY23 Sales increase 136% on FY22 Sales
From Immuron Limited
Via GlobeNewswire
Immuron Chairman Transition
From Immuron Limited
Via GlobeNewswire
Immuron Business Update: Letter to Shareholders
From Immuron Limited
Via GlobeNewswire
Immuron Initiates Recruitment of Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Edges Higher; Six Flags Reports Upbeat Results
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March
Via Benzinga
Palantir (PLTR) Stock Pops Ahead of Earnings
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Tupperware Brands (TUP) Stock Down 8% Today?
Via InvestorPlace
Why Is Aptorum (APM) Stock Down 16% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.